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biochemically. The predicted dose of Pamidronate to achieve a
normal alkaline phosphatase (ALP) and fasting urinary
hydroxyproline/creatinine ratio (HYPRO) was calculated and
administered as weekly infusions of either 30 or 45 mg.
In all 10 patients in the previously untreated group. ALP fell into
the upper normal range; there was a slight tendency for a greater
than expected fall in ALP (p<0.05). Only 7/10 patients achieved
normal HYPRO values, but this tendency to underpredict the fall in
HYPRO was not statistically significant. For the 5 patients in the
relapsing group, the actual reductions in ALP and HYPRO were
much less than expected and none of these patients achieved
biochemical remission.
In conclusion, the BPS model for predicting the dose of
Pamidronate to achieve biochemical remission works well in
previously untreated patients, but not for patients who are
relapsing.
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BACTERIAL OVERGROWTH AND
METHYLAMINE EXCRETION IN THE ELDERLY
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The bacterial by-products of choline metabolism are absorbed in
the duodenum and excreted via the kidneys. It has been suggested
that small intestinal bacterial overgrowth (SIBO) may augment this
process and produce toxic metabolites of choline; methylamines
[Simenhoff el al. 1976. Lancet 2, 818-21). Intestinal bacteria
exposed to choline in vitro have been shown to produce these
metabolites [Johnson et al. 1977, Med. Lab. Sri. 34,131-43].
As methylamines have the potential to form carcinogenic
precursors, and to alter the bioavailibiliry of certain orally
administered drugs, SIBO may therefore be implicated in these
toxic processes.
Aims: (i) To determine if urinary dimethylamine (DMA), an end-
metabolite of choline metabolism, is a reliable means of
diagnosing SIBO, and (ii) to assess if the presence of certain small
bowel organisms is associated with raised urinary DMA levels.
Methods: Urinary DMA (uraol/1) was measured by gas liquid
chromatography after choline ingestion, in a group of elderly
patients: 18 culture proven SIBO, including II with strict
anaerobes, and 7 culture negatives.
The presence of each of the bacterial species: Bacteroides,
Clostridium, Enterobaaeriaceae, Peptostreptococcus, Veillonella
and Grant positive non-sporing rods was studied in relation to
DMA excretion.
Results: Urinary DMA; (i) did not differ between controls and the
elderly patient group (P>0.05), (ii) did not differ between the
SIBO and culture negative groups (P>0.05), (iii) was not raised in
the presence of small bowel anaerobes, and (iv) did not correlate
significantly with total bacterial counts (r=0.2), or, strict anaerobic
counts (r=0.1). The presence of Peptostreptococcus spp. was
associated with the highest DMA production amongst the
individual species (PO.05).
Conclusion: Urinary DMA is not a reliable marker of SIBO and it
is unlikely that methylamine production is increased as a result of
SIBO in the elderly.
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Many existing methods of measuring quality of life (QoL) may be
more accurately described as measures of health status or life
satisfaction. Such measures generally impose external value
systems on the individual. Judgement analysis (J A), derived from
social judgement theory, permits individual judgements to be
modelled mathematically. The Schedule for the Evaluation of
Individual Quality of life (SEIQoL) was developed by adapting
JA to QoL measurement allowing individuals to describe their
QoL in terms of those factors which they consider important
[O'Boyle et al. 1992, Lancet, 1088-1091]
Aims: The purpose of the present study was to evaluate the
feasibility, validity and reliability of using the S El QoL to measure
the QoL of dementia patients.
Methods: The SEIQoL was administered to 20 patients meeting
DSM-uTR criteria for mild dementia (IS female, 5 male; mean age
=73, range 67-81) Cognitive status was evaluated by CAMCOG
from CAMDEX (mean=70.75, range 56-86)).and the Mini-Mental
State Examination (mean=22.75, range 19-27).
Results: All patients were able to complete some elements of the
SEIQoL. but only 6 were willing or able to complete the full
version. Mean CAMCOG scores distinguished this group of 6
patients from the remaining 14 (t = 3.5, pO.OI). Mean internal
variance (R-) provides one estimate of construct validity, and the
internal reliability coefficient (r) provides a measure of judgement
reliability. For the 6 patients who completed the SEIQoL mean R2
=0.70 (sd=0.11, range=0.57-0.83) and mean r=0.74 (sd=0.20,
range=0.42-0.97), both of which compare favourably with
normative data.
Conclusion: For dementia patients with mild cognitive impairment
the SEIQoL can provide a feasible, valid and reliable measure of
QoL. With increasing cognitive impairment patients are less likely
to be able or willing to complete the SEIQoL.
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The use of oral anticoagulants and aspirin
for the primary prevention of stroke In
elderly patients with atrial fibrillation.
(AF), is controversial. To establish current
practice a questionnaire was circulated to
300 geriatricians, (G) and 300 cardiologists
(C). The response rate was 51\ G and 47\ C.
The table shows the \ of consultants who
prescribe warfarin in conditions associated
with AF in otherwise "fit" elderly.
Diagnosis. (?70 years) G(%) C(%)
Mixed Aortic Valve
Disease (AVD) 37 24 p<0.05
Dilated Cardiomvopathy
(DCM) " 52 86 p<0.01
